295 related articles for article (PubMed ID: 15990761)
1. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
Ahmed A; Centor RM; Weaver MT; Perry GJ
Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
[TBL] [Abstract][Full Text] [Related]
2. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
5. Renal insufficiency as an independent predictor of mortality among women with heart failure.
Bibbins-Domingo K; Lin F; Vittinghoff E; Barrett-Connor E; Grady D; Shlipak MG
J Am Coll Cardiol; 2004 Oct; 44(8):1593-600. PubMed ID: 15489091
[TBL] [Abstract][Full Text] [Related]
6. Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications.
Ahmed A; Kiefe CI; Allman RM; Sims RV; DeLong JF
J Am Geriatr Soc; 2002 Oct; 50(10):1659-66. PubMed ID: 12366619
[TBL] [Abstract][Full Text] [Related]
7. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium.
Arch Intern Med; 1997 May; 157(10):1103-8. PubMed ID: 9164376
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure.
Tribouilloy C; Rusinaru D; Leborgne L; Peltier M; Massy Z; Slama M
Am J Cardiol; 2008 Mar; 101(5):639-44. PubMed ID: 18308013
[TBL] [Abstract][Full Text] [Related]
9. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
Grigorian Shamagian L; Roman AV; Ramos PM; Veloso PR; Bandin Dieguez MA; Gonzalez-Juanatey JR
J Card Fail; 2006 Mar; 12(2):128-33. PubMed ID: 16520261
[TBL] [Abstract][Full Text] [Related]
11. Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community.
Rochon PA; Sykora K; Bronskill SE; Mamdani M; Anderson GM; Gurwitz JH; Gill S; Tu JV; Laupacis A
J Gen Intern Med; 2004 Jun; 19(6):676-83. PubMed ID: 15209607
[TBL] [Abstract][Full Text] [Related]
12. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
Ezekowitz J; McAlister FA; Humphries KH; Norris CM; Tonelli M; Ghali WA; Knudtson ML;
J Am Coll Cardiol; 2004 Oct; 44(8):1587-92. PubMed ID: 15489090
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitor use and mortality reduction: do controlled trial results equal clinical practice?
Schade CP; Hannah KL; Rezek G; Brehm JG
W V Med J; 2006; 102(1):304-6. PubMed ID: 16706321
[TBL] [Abstract][Full Text] [Related]
14. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
15. Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients.
Ahmed A; Allman RM; DeLong JF; Bodner EV; Howard G
South Med J; 2002 Jul; 95(7):703-10. PubMed ID: 12144075
[TBL] [Abstract][Full Text] [Related]
16. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
[TBL] [Abstract][Full Text] [Related]
17. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
[TBL] [Abstract][Full Text] [Related]
18. Treatment and risk in heart failure: gaps in evidence or quality?
Peterson PN; Rumsfeld JS; Liang L; Hernandez AF; Peterson ED; Fonarow GC; Masoudi FA;
Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):309-15. PubMed ID: 20388872
[TBL] [Abstract][Full Text] [Related]
19. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
Andersson B; Kjörk E; Brunlöf G
Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
[TBL] [Abstract][Full Text] [Related]
20. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
